Company intelligence
Bachem
Leading Partner in Tides.
Pharmaceutical Manufacturing
Bubendorf, CH
2,166 employees
Founded 1971
3 public signals
About Bachem
The Swiss-based Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides. With over 50 years of experience and expertise Bachem provides products for research, clinical development and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services. Bachem operates internationally with headquarters in Switzerland and locations in Europe, the US and Asia.
Verified activity
Signals from Bachem
3 published signals
Presence & Recognition
Bachem is opening its doors in Bubendorf on September 18th to showcase its workplace and engage with visitors.
Reported by Bachem
Presence & Recognition
Bachem is hosting a webinar on 20 October 2026 featuring Ivan Zemskov, Group leader R&D and Patrizia Marchetti, Senior group leader, TechOps MPT, to explore API concentration technologies.
Reported by Bachem
Presence & Recognition
Bachem is hosting a presentation at the Boulder Peptide Symposium on 29 September 2026 to discuss API concentration bottlenecks and concentration strategies.
Reported by Bachem